Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Pieter Jan Van Dam"'
Autor:
Tim Muilwijk, Loïc Baekelandt, Murat Akand, Sofie Daelemans, Koen Marien, Yannick Waumans, Pieter-Jan van Dam, Mark Kockx, Thomas Van den Broeck, Ben Van Cleynenbreugel, Frank Van der Aa, Thomas Gevaert, Steven Joniau
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 67-74 (2024)
Background and objective: The tumor microenvironment (TME) in non–muscle-invasive bladder cancer (NMIBC) plays an important role in the anticancer response. We aimed to identify the prognostic biomarkers in the TME of patients with NMIBC for progre
Externí odkaz:
https://doaj.org/article/6a15f4e11a4e4f86bfac6ff265de9483
Publikováno v:
Nursing Reports, Vol 12, Iss 4, Pp 850-860 (2022)
Healthcare workers are under increasing pressure to use limited resources more efficiently and improve patient outcomes. Healthcare redesign, a quality improvement methodology derived from the automotive industry, is a proven means of achieving these
Externí odkaz:
https://doaj.org/article/f944d00f782443c080810989257f67df
Autor:
Bernadett Szabados, Mark Kockx, Zoe June Assaf, Pieter-Jan van Dam, Alejo Rodriguez-Vida, Ignacio Duran, Simon J. Crabb, Michiel S. Van Der Heijden, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, Maria Jose Mendez, Cristina Suarez, Mark Linch, Aaron Prendergast, Charlotte Tyson, Diana Stanoeva, Sofie Daelemans, Miche Rombouts, Sanjeev Mariathasan, Joy S. Tea, Kelly Mousa, Shruti Sharma, Alexey Aleshin, Romain Banchereau, Daniel Castellano, Thomas Powles
Publikováno v:
European urology
[Background] Neoadjuvant immunotherapies hold promise in muscle-invasive bladder cancer (MIBC).
[Objective] To report on 2-yr disease-free (DFS) and overall (OS) survival including novel tissue-based biomarkers and circulating tumor DNA (ctDNA)
[Objective] To report on 2-yr disease-free (DFS) and overall (OS) survival including novel tissue-based biomarkers and circulating tumor DNA (ctDNA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52be113364becd0e44b3fcaf865708b0
https://doi.org/10.1016/j.eururo.2022.04.013
https://doi.org/10.1016/j.eururo.2022.04.013
Autor:
Markus Mayrhofer, Bram De Laere, Tom Whitington, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey, Lucien Hoekx, Dirk Schrijvers, Barbara Brouwers, Willem Lybaert, Els Everaert, Daan De Maeseneer, Michiel Strijbos, Alain Bols, Karen Fransis, Steffi Oeyen, Pieter-Jan van Dam, Gert Van den Eynden, Annemie Rutten, Markus Aly, Tobias Nordström, Steven Van Laere, Mattias Rantalainen, Prabhakar Rajan, Lars Egevad, Anders Ullén, Jeffrey Yachnin, Luc Dirix, Henrik Grönberg, Johan Lindberg
Publikováno v:
Genome Medicine, Vol 10, Iss 1, Pp 1-13 (2018)
Abstract Background There are multiple existing and emerging therapeutic avenues for metastatic prostate cancer, with a common denominator, which is the need for predictive biomarkers. Circulating tumor DNA (ctDNA) has the potential to cost-efficient
Externí odkaz:
https://doaj.org/article/4783b889dd4d4c3c8abf60a59cf0a086
Autor:
Anja Brouwer, Bram De Laere, Pieter-Jan van Dam, Dieter Peeters, Jasper Van Haver, Ellen Sluydts, Ali El Moussaoui, Pauline Mendelaar, Jaco Kraan, Marc Peeters, Steven Van Laere, Luc Dirix
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0220906 (2019)
BACKGROUND:Personalized targeted treatment in metastatic breast cancer relies on accurate assessment of molecular aberrations, e.g. overexpression of Human Epidermal growth factor Receptor 2 (HER-2). Molecular interrogation of circulating tumor cells
Externí odkaz:
https://doaj.org/article/99e9d48bbe204e35b772388cacc3293f
Background. Liquid biopsies have been studied as an accessible method to capture spatial tumour heterogeneity and repeatedly evaluate targetable aberrations in cancer. Here, we analysed pure single and pools of circulating and disseminated tumour cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a481746d6c8a2c45ee1cd0cce299cfc7
https://doi.org/10.21203/rs.3.rs-2824422/v1
https://doi.org/10.21203/rs.3.rs-2824422/v1
Publikováno v:
Healthcare; Volume 10; Issue 5; Pages: 842
The Australian state of Tasmania has seen a spike in Emergency Department presentations in recent years, particularly among the elderly. A novel extended scope occupational therapy (ESOT) service was implemented by the Tasmanian Health Service, aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03f404681afb5b47e725a75b5587dc25
https://pubmed.ncbi.nlm.nih.gov/35627979
https://pubmed.ncbi.nlm.nih.gov/35627979
Autor:
Pieter Jan Van Dam, Diane Caney, Richard C. Turner, Phoebe Griffin, Mitchell Dwyer, Sarah Prior
Publikováno v:
The Australian journal of rural health. 30(2)
To understand the experiences of vulnerable clients who used telehealth during the Coronavirus pandemic.The study employed a qualitative enquiry, utilising semi-structured interviews lasting 30-60 minutes with a thematic analysis approach to explore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7a66509abf6bd8b360faf3a3060b11
https://pubmed.ncbi.nlm.nih.gov/35076149
https://pubmed.ncbi.nlm.nih.gov/35076149
Publikováno v:
Healthcare. 10:753
Computed tomography pulmonary angiography (CTPA) has become the most widely used technique for diagnosis or exclusion of a pulmonary embolism (PE). It has been suggested that overuse of this imaging type may be prevalent, especially in emergency depa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d78cb89c831c6431c7f122c9edc4812
https://doi.org/10.3390/healthcare10050753
https://doi.org/10.3390/healthcare10050753
Autor:
Axel Bex, Yasmin Abu-Ghanem, Johannes V. Van Thienen, Niels Graafland, Brunolf Lagerveld, Patricia Zondervan, Harrie Beerlage, Jeroen van Moorselaar, Mark Kockx, Pieter-Jan Van Dam, Bernadett Szabados, Christian U. Blank, Thomas Powles, John B. A. G. Haanen
Publikováno v:
Journal of Clinical Oncology. 40:289-289
289 Background: Antibodies targeting PD-1/PD-L1 combined with vascular endothelial growth factor (VEGF) inhibitors are a first-line standard of care for metastatic RCC. Neoadjuvant use of these combinations may lead to downstaging and reduce the risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f04f9875733cec64284f5568f1afda91
https://doi.org/10.1200/jco.2022.40.6_suppl.289
https://doi.org/10.1200/jco.2022.40.6_suppl.289